DJ Gilead Sciences Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) shed 1.97% to $153.11 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.41% to 7,690.73 and the Dow Jones Industrial Average falling 0.07% to 51,966.03.
This was the stock's second consecutive day of losses.
Gilead Sciences Inc. closed 4.61% below its 52-week high of $160.51, which the company achieved on October 15th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.69% to $253.79, Pfizer Inc. $(PFE)$ fell 0.47% to $29.44, and Abbott Laboratories $(ABT)$ fell 0.79% to $104.06.
Trading volume (5.6 M) remained 123,407 below its 50-day average volume of 5.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 19, 2026.
Comments